Observed reduction in the diagnosis of acute lymphoblastic leukaemia in children during the COVID-19 pandemic

Acta Paediatr. 2021 Feb;110(2):596-597. doi: 10.1111/apa.15576. Epub 2020 Oct 5.

Authors

Kirsten Brunsvig Jarvis^{1

2}, Andreas Lind³, Marissa LeBlanc⁴, Ellen Ruud^{1

5}

Affiliations

¹ Department of Paediatric Haematology and Oncology, Oslo University Hospital HF, Oslo, Norway.
² Department of Paediatric Research, Oslo University Hospital HF, Oslo, Norway.
³ Department of Microbiology, Oslo University Hospital HF, Oslo, Norway.
⁴ Oslo Center for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.
⁵ Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

No abstract available

MeSH terms

Adolescent
COVID-19 / epidemiology*
Child
Child, Preschool
Humans
Infant
Infant, Newborn
Norway / epidemiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / epidemiology*